Literature DB >> 8467874

The interaction of selective and non-selective antagonists with pre- and postjunctional muscarinic receptor subtypes in the guinea pig trachea.

R E Ten Berge1, A F Roffel, J Zaagsma.   

Abstract

Muscarinic receptor antagonists were used to study prejunctional M2 and postjunctional M3 receptors in the isolated guinea pig trachea. The effects of four M2-selective muscarinic receptor antagonists (gallamine, methoctramine, AQ-RA 741 and AF-DX 116) were studied on twitch contractions, elicited by electrical field stimulation, of tracheal ring preparations. M1-selective (pirenzepine, (+)- and (-)-telenzepine), M3-selective (4-DAMP-methobromide and UH-AH 371) and non-selective (atropine and ipratropium) muscarinic receptor antagonists were also used. The clear potentiation of the twitch contractions and the subsequent strong inhibition observed with M2-selective antagonists demonstrate antagonism at prejunctional M2 and postjunctional M3 muscarinic receptors, respectively. The maximal potentiation correlated well with the M2/M3-selectivity known from binding experiments: gallamine > methoctramine > AQ-RA 741 > AF-DX 116. Strong correlations were also found between the pEC20 values for potentiation of the twitch response and the pKi values for bovine cardiac M2 muscarinic receptors and between the pIC50 values for inhibition of the twitch response and the pA2 values for M3 muscarinic receptors as determined on non-stimulated methacholine-contracted tracheal smooth muscle preparations. Thus, study of the effects of a wide concentration range of putative M2-selective muscarinic receptor antagonists on the twitch contractions of single tracheal rings induced by low-intensity electrical field stimulation yields information about M2/M3 receptor selectivity and about prejunctional M2 and postjunctional M3 receptor affinity within the same experiment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467874     DOI: 10.1016/0014-2999(93)90062-m

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Differences in the prejunctional effects of methacholine and pilocarpine on the release of endogenous acetylcholine from guinea-pig trachea.

Authors:  R E ten Berge; E C Weening; A F Roffel; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Conditional involvement of muscarinic M1 receptors in vagally mediated contraction of guinea-pig bronchi.

Authors:  R E ten Berge; A F Roffel; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

3.  Effects of neostigmine on bronchoconstriction with continuous electrical stimulation in rats.

Authors:  Koji Ishii; Osamu Shibata; Kenji Nishioka; Atsushi Tsuda; Tetsuji Makita; Koji Sumikawa
Journal:  J Anesth       Date:  2011-11-01       Impact factor: 2.078

4.  Effects of muscarinic M2 and M3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro.

Authors:  N Watson; R M Eglen
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 5.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

7.  Dysfunction of muscarinic M2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs.

Authors:  R E ten Berge; R E Santing; J J Hamstra; A F Roffel; J Zaagsma
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

Review 8.  Muscarinic receptor signaling in the pathophysiology of asthma and COPD.

Authors:  Reinoud Gosens; Johan Zaagsma; Herman Meurs; Andrew J Halayko
Journal:  Respir Res       Date:  2006-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.